In 1992-93, the US Environmental Protection Agency (USEPA) convened a negotiated rulemaking process under the Federal Advisory Committee Act (FACA) to develop a consensus approach to simultaneously addressing potential health risks posed by disinfection by-products (DBPs) and waterborne pathogens.
The fact that inadvertent risk-risk tradeoffs might be made between protection from DBPs and protection from microbial pathogens complicates the process.
It is further complicated by uncertainties that affect the assessment of both risks.
The regulatory-negotiations committee devised a staged approach to regulation that a second FACA committee finalized in 1996-97.
This article summarizes the DBPs side of the benefit-cost analysis that was developed during these processes and later refined by USEPA to more fully address uncertainties regarding the rule's benefits.
Mots-clés Pascal : Traitement eau potable, Désinfection, Produit réaction, Tumeur maligne, Analyse avantage coût, Etats Unis, Amérique du Nord, Amérique, Législation
Mots-clés Pascal anglais : Drinking water treatment, Disinfection, Reaction product, Malignant tumor, Cost benefit analysis, United States, North America, America, Legislation
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0240739
Code Inist : 001D16A02. Création : 16/11/1999.